Every material Form 8-K Talon Capital Corp. filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Talon Capital Corp., a special purpose acquisition company, appointed Dr. Victoria Ivashina as an independent director effective September 11, 2026, and to its audit committee. She is a Harvard Business School finance professor and a trustee of two Carlyle AlpInvest private markets funds. The filing reports no financial results, and the change is an administrative board addition.
Board appointed Dr. Victoria Ivashina as independent director effective September 11, 2026, and to the audit committee on the same date.
Dr. Ivashina is the Lovett-Learned Professor of Finance at Harvard Business School, and has served as a trustee of two Carlyle AlpInvest private markets funds since 2022.
Sponsor Talon Capital Sponsor LLC transferred 20,000 Class B ordinary shares to Dr. Ivashina under a September 11, 2026 agreement at approximately $0.003 per share.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Talon Capital Corp. filing is on SEC EDGAR ↗. 8-K briefs of other companies →